Skip to Main Content

Author Details

Koen van Besien
University Hospitals of Cleveland
1988
332
60
PMIDPaper TitleJournal TitlePublished Year
37801604XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.Cancer Res2024
36334653Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients.Transplant Cell Ther2023
37045941Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).Bone Marrow Transplant2023
37142568Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.Cell Death Dis2023
36739088Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation.Transplant Cell Ther2023
36939851Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.Eur Heart J2023
36796016Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.Blood2023
34320785Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas.Haematologica2022
35404315Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience.J Immunother2022
35724850Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation.Transplant Cell Ther2022
35661836C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.Bone Marrow Transplant2022
34864913Reply to Caldwell et al.Clin Infect Dis2022
34818964Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match!Leuk Lymphoma2022
34643477Adenovirus viremia after <i>in vivo</i> T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes.Leuk Lymphoma2022
34668824Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults.Leuk Lymphoma2022
32681658MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.Clin Exp Immunol2021
33586581Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma.Leuk Lymphoma2021
33811020Colonization with Gastrointestinal Pathogens Prior to Hematopoietic Cell Transplantation and Associated Clinical Implications.Transplant Cell Ther2021
34586001Maintenance therapy after allogeneic transplant for acute myeloid leukemia: great expectations.Leuk Lymphoma2021
34507002Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.Transplant Cell Ther2021
33956965Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.Clin Infect Dis2021
33257776Cord blood maternal microchimerism following unrelated cord blood transplantation.Bone Marrow Transplant2021
33356693Is less more? Viewpoint on empiric vancomycin therapy of fever and neutropenia after allogeneic stem cell transplantation.Leuk Lymphoma2021
32518291Cord blood transplants supported by unrelated donor CD34<sup>+</sup> progenitor cells.Bone Marrow Transplant2020
32024039Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant <i>Candida tropicalis</i>: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies.J Fungi (Basel)2020
32048529Combining haplo-identical and cord blood stem cell grafts - might the whole be greater than the sum of its parts?Leuk Lymphoma2020
32045475Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.Blood Adv2020
31891814Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies.Biol Blood Marrow Transplant2020
31687767Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients.Clin Infect Dis2020
32092137KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.Blood Adv2020
33361336Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma.J Immunother Cancer2020
33151264Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma.JAMA Oncol2020
33091124Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response.Blood Adv2020
32662880Hematology and oncology clinical care during the coronavirus disease 2019 pandemic.CA Cancer J Clin2020
32654572Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation.Leuk Lymphoma2020
32643489Hematological manifestations of COVID-19.Leuk Lymphoma2020
32924711Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?Leuk Lymphoma2020
32449254Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir.Transpl Infect Dis2020
32476524Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?Leuk Lymphoma2020
32336184An update on options of therapy for aggressive mantle cell lymphoma.Leuk Lymphoma2020
32142395Alternative Donor Transplantation for Lymphoid Malignancies: How Far We Have Come.J Clin Oncol2020
30661542Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.Biol Blood Marrow Transplant2019
32128335Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient.Open Forum Infect Dis2019
29966478A renaissance for autologous transplantation in follicular lymphoma?Leuk Lymphoma2019
31217161Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.Blood Adv2019
31238818Donor graft genotypes versus leukemia.Leuk Lymphoma2019
31238760Tocilizumab, in search for a role in acute GVHD.Leuk Lymphoma2019
31337787Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.Sci Rep2019
31592503Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.JCO Precis Oncol2019
31190006High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.Bone Marrow Transplant2019
  • 1 - 50 of 332

Recommended Authors

Lohith Gowda
Yale Cancer Center and Yale School of Medicine
Career Start Year 2018
Number of shared co-authors 2
Sawa Ito
University of Pittsburgh
Career Start Year 2013
Number of shared co-authors 2
Molly Maloy
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 2
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 5
Aarthi Shenoy
MedStar Washington Hospital Center
Career Start Year 2006
Number of shared co-authors 1
Geoffrey D E Cuvelier
University of Manitoba
Career Start Year 2005
Number of shared co-authors 1
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 10
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 6
Kristin Baird
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 2
Laura F Newell
Oregon Health and Science University
Career Start Year 2003
Number of shared co-authors 6
Eneida R Nemecek
Oregon Health Sciences University
Career Start Year 2002
Number of shared co-authors 4
Ivan Pasic
Princess Margaret Cancer Centre
Career Start Year 2001
Number of shared co-authors 0
Emmanuel Raffoux
Universite Paris Diderot
Career Start Year 1998
Number of shared co-authors 6
Leslie Lehmann
Dana Farber Cancer Institute/Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 0
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 15
Gabrielle Meyers
Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 4
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 2
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 13
Paul L Martin
Duke University Medical Center
Career Start Year 1990
Number of shared co-authors 3
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 3
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 13
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1986
Number of shared co-authors 7
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 5
Joanne Kurtzberg
Marcus Center for Cellular Cures, Duke University School of Medicine
Career Start Year 1983
Number of shared co-authors 7
Dietger Niederwieser
University of Leipzig
Career Start Year 1982
Number of shared co-authors 9
Kenneth B Miller
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 4
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 0
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 0
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Career Start Year 1976
Number of shared co-authors 8
Robin Fo??
Sapienza University.
Career Start Year 1968
Number of shared co-authors 8

Collaborators

Lucy A Godley
The University of Chicago
Co-authored papers 26
Richard T Maziarz
Oregon Health & Science University
Co-authored papers 14
Michele Donato
Co-authored papers 9
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 7
Todd M Zimmerman
Co-authored papers 6
Hanna Rennert
New York NewYork-Presbyterian Hospital
Co-authored papers 6
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers 5
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Co-authored papers 5
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 4
Jorge Cortes
Georgia Cancer Center
Co-authored papers 4
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Co-authored papers 3
Andrea Sboner
Institute for Computational Biomedicine
Co-authored papers 3
Kenneth C Anderson
Dana Farber Cancer Institute
Co-authored papers 3
John T Schiller
David Geffen School of Medicine at university of california los angeles
Co-authored papers 3
Ravi Vij
Co-authored papers 3
Olivier Elemento
Meyer Cancer Center
Co-authored papers 3
Kate Swanson
University of California san francisco
Co-authored papers 3
Steven Z Pavletic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Craig C Hofmeister
Co-authored papers 2
Mary Territo
Co-authored papers 2
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers 2
Tuo Zhang
Weill Cornell Medical College.
Co-authored papers 2
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 2
Manish A Shah
Weill Cornell University
Co-authored papers 2
David M Nanus
Sandra and Edward Meyer Cancer Center
Co-authored papers 2
Brandon Hayes-Lattin
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 2
Andrew M Evens
Rutgers Robert Wood Johnson Medical School
Co-authored papers 2
Moshe Talpaz
University of Michigan Rogel Cancer Center.
Co-authored papers 2
Release 1.2